Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
Status unconfirmed · Early Phase 1
Conditions studied: Glaucoma, Open-Angle
In brief
Investigate changes in optical coherence tomography angiography of the optic nerve and macula following topical instillation of commercial preparations of netarsudil 0.02% ophthalmic solution.
Key facts
- Study ID
- NCT04234932
- Run by
- University of the Incarnate Word
- People needed
- 10
- Starts
- 2020-01-06
- Expected to finish
- 2021-01-01
- Last updated by the study team
- 2020-04-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Normal ocular health
You may not qualify if…
- Females who are or may be pregnant or who are nursing
- Uncontrolled hypertension
- Allergy to netarsudil or latanoprost
Where it is running
- University of the Incarnate Word — San Antonio, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.